Trial
NCT03535675
Muscadine Plus (MPX) In Men With Prostate Cancer
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborators
Greater Washington Community Foundation
Condition
Adenocarcinoma of the Prostate
Intervention
Muscadine Plus
Why stopped
The study was terminated by DSMB due to futility.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-05-22